Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Besser

Baseline Clinical and Pet-Ct Tumor Burden Parameters Do Not Predict Outcome of Relapse/Refractory Aggressive B Cell Lymphoma Patients Treated With Anti-Cd19 Car T-Cells

Hematological Oncology

English

Determinants of Outcome in Melanoma Patients With Cerebral Metastases

Journal of Clinical Oncology

English

Related publications

Cd19/Cd20-Redirected Bispecific Car T Cell Treatment in Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Hematological Oncology

English

Cytokine Release Syndrome and Neurotoxicity by Baseline Tumor Burden in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With Tisagenlecleucel

Hematological Oncology

English

Rapid Relapse of Large B‐Cell Lymphoma After CD19 Directed CAR‐T‐Cell Therapy Due to CD‐19 Antigen Loss

American Journal of Hematology

Hematology

2019

English

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

British Journal of Haematology

Hematology

2018

English

Potent Anti-Leukemia Activities of Humanized CD19-targeted CAR-T Cells in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

American Journal of Hematology

Hematology

2018

English

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B- And T-Cell Lymphoma

Hematological Oncology

English

Metabolic Heterogeneity of Baseline 18-FDG Pet-Ct Scan Predicts Outcome in Primary Mediastinal B-Cell Lymphoma.

Hematological Oncology

English

Anti-Cd19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Frontiers in Oncology

Cancer Research

Oncology

2019

English

Predictive Value of PET Response Combined With Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients

Journal of Nuclear Medicine

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Besser

Baseline Clinical and Pet-Ct Tumor Burden Parameters Do Not Predict Outcome of Relapse/Refractory Aggressive B Cell Lymphoma Patients Treated With Anti-Cd19 Car T-Cells

Determinants of Outcome in Melanoma Patients With Cerebral Metastases

Related publications

Cd19/Cd20-Redirected Bispecific Car T Cell Treatment in Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Cytokine Release Syndrome and Neurotoxicity by Baseline Tumor Burden in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With Tisagenlecleucel

Rapid Relapse of Large B‐Cell Lymphoma After CD19 Directed CAR‐T‐Cell Therapy Due to CD‐19 Antigen Loss

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

Potent Anti-Leukemia Activities of Humanized CD19-targeted CAR-T Cells in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B- And T-Cell Lymphoma

Metabolic Heterogeneity of Baseline 18-FDG Pet-Ct Scan Predicts Outcome in Primary Mediastinal B-Cell Lymphoma.

Anti-Cd19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Predictive Value of PET Response Combined With Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients